Pre-Hypertension Clinical Trial
Official title:
Acute Effects of Intermittent Respiratory Muscle Training and Hypoxia on Cardiovascular and Sleep Parameters in Elderly Persons With Prehypertension
Verified date | August 2018 |
Source | Swiss Federal Institute of Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The prevalence of pre-hypertension and hypertension in the elderly is very high. Apart from medication, physical exercise training is a potential strategy to reduce blood pressure, however, the ability to perform exercise can be limited in the elderly. Hence, alternative non-pharmacological strategies to reduce blood pressure are necessary. Two interventions that have been shown to positively influence blood pressure are respiratory muscle training (RMT) and intermittent hypoxia (IH). Whether a combination of RMT and IH yields even better effects is currently unknown. Therefore, in this study, the effect of a single session of RMT with and without IH on blood pressure and associated cardiovascular parameters will be investigated in elderly subjects with pre-hypertension.
Status | Completed |
Enrollment | 14 |
Est. completion date | July 4, 2018 |
Est. primary completion date | July 4, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Age: 65-80 years - Systolic blood pressure between 130-139 mmHg and diastolic blood pressure lower than 90 mmHg - Non smoking - Normal Body-Mass-Index (BMI): 18.5-24.9 kg·m-2 - Normal Lung Function - Willing to adhere to the general study rules Exclusion Criteria: - Known or suspected non-compliance, drug or alcohol abuse - Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant - Previous enrolment into the current study - Enrolment of the investigator, his/her family members, employees and other dependent persons - Intake of blood pressure medication - Intake of medications affecting sleep or the performance or the respiratory, cardiovascular or neuromuscular system - Acute or chronic illness other than prehypertension |
Country | Name | City | State |
---|---|---|---|
Switzerland | Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich | Zurich | ZH |
Lead Sponsor | Collaborator |
---|---|
Swiss Federal Institute of Technology |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in blood pressure in mmHg | Blood pressure before, during, and after each intervention measured with an automated sphygmomanometer | At baseline after 20 min of lying in a supine position, every 5 minutes during the 60 min intervention, and 20, 35 and 50 min after the end of the intervention | |
Secondary | Change in pulse wave velocity in m/s | Carotid-femoral pulse wave velocity before and after each intervention, assessed with a device that simultaneously records (non-invasively) pressure signals from the carotid and femoral arteries | At baseline after 25 min of lying in a supine position, and 25, 40 and 55 min after the end of the intervention | |
Secondary | Change in cardiac output in L/min | Cardiac output before, during, and after each intervention measured with impedance cardiography | At baseline after 15min of lying in a supine position, every 5 minutes during the 60 min intervention, and 15, 30 and 45 min after the end of the intervention | |
Secondary | Change in total peripheral resistance in dyn x s/cm^5 | Total peripheral resistance before, during, and after each intervention measured with impedance cardiography | At baseline after 15min of lying in a supine position, every 5 minutes during the 60 min intervention, and 15, 30 and 45 min after the end of the intervention | |
Secondary | Changes in baroreflex sensitivity in ms/mmHg | Baroreflex sensitivity before and after each intervention assessed with photo plethysmography | At baseline after 15min of lying in a supine position, and 15, 30 and 45 min after the end of the intervention | |
Secondary | Change in heart rate variability in ms | Heart rate variability measured before, during and after each intervention with impedance cardiography | At baseline after 15min of lying in a supine position, every 5 minutes during the 60 min intervention, and 15, 30 and 45 min after the end of the intervention | |
Secondary | Change in peripheral oxygenation during sleep in %Saturation | Peripheral oxygenation during sleep measured at home after each intervention with a finger pulse oxymeter | Continuously during the night following each intervention, from time to bed until wake up time in the morning (i.e. on average approximately 8hours) | |
Secondary | Change in sleep efficiency defined as the ratio of total sleep time and time in bed | Sleep efficiency measured at home after each intervention with an actigraph | Continuously during the night following each intervention, from time to bed until wake up time in the morning (i.e. on average approximately 8hours) | |
Secondary | Change in subjective sleep quality | Sleep quality (i.e. "How well did you sleep?" and "How recovered are you?") measured at home after each intervention with a visual analog scale (VAS). The two VAS consists each of a 10cm-horizontal line, with the left end of the lines representing low sleep quality ("slept very badly" and "not recovered at all", respectively) and the right end representing good sleep quality ("slept very well" and "completely recovered", respectively). Participants are asked to draw a vertical line in between the two ends on each of the two VAS. | Within 5 minutes after waking-up following the night after each intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01741779 -
Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function
|
N/A | |
Withdrawn |
NCT01074918 -
Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients
|
Phase 1/Phase 2 | |
Completed |
NCT00288158 -
Primary Prevention of Hypertension in Obese Adolescents
|
Phase 2 | |
Completed |
NCT01190319 -
Study: Effects of Strawberries on Blood Pressure
|
N/A | |
Completed |
NCT01008176 -
Restoring Sleep Homeostasis to Lower Blood Pressure
|
N/A | |
Unknown status |
NCT02197910 -
Different Dosages of Bioactive Wheat Peptides and Blood Pressure Level and CVD Risk Biomarkers in Healthy Subjects
|
N/A | |
Recruiting |
NCT04543656 -
Personalized Blood Pressure Care Using IoMTs and Artificial Intelligence
|
N/A | |
Completed |
NCT03168789 -
Tension Tamer Randomized Control Trial
|
N/A | |
Completed |
NCT00553969 -
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
|
Phase 1/Phase 2 | |
Completed |
NCT00170937 -
A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
|
Phase 4 | |
Completed |
NCT01741766 -
The Effects of Stretching Training on Arterial Function and Autonomic Control
|
N/A | |
Completed |
NCT02143817 -
Whole Body Vibration Combined With L-citrulline Supplementation on Cardiovascular Function and Body Composition
|
N/A | |
Terminated |
NCT00388388 -
Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects
|
Phase 2 | |
Completed |
NCT02148458 -
Short Term Intermittent Fasting and Mediterranean Diet
|
N/A | |
Terminated |
NCT01349114 -
Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects
|
Phase 4 | |
Completed |
NCT02038179 -
Center of Research Translation (CORT) Project 2
|
Phase 2/Phase 3 | |
Completed |
NCT01202175 -
Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension
|
Phase 4 | |
Completed |
NCT00970931 -
Hypertension Prevention in Pre-Hypertensive Individuals
|
Phase 3 | |
Completed |
NCT01841840 -
The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke
|
N/A | |
Not yet recruiting |
NCT01364675 -
Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects
|
N/A |